Jenburkt Pharmaceuticals Ltd, founded in 1985 by the Bhuta family, specializes in manufacturing and marketing high-quality pharmaceutical formulations and healthcare products. With a strong presence in both domestic and international markets, the company distributes its products across India and in 13 other countries, reaching over 400,000 pharmacies globally. Jenburkt operates a WHO-compliant manufacturing facility in Sihor, Gujarat, and a government-approved R&D unit, ensuring adherence to Good Manufacturing Practices (GMP).
The company serves various sectors, including government and semi-government institutions, missionary hospitals, and public sector enterprises, highlighting its widespread impact in the healthcare industry. In 2021-22, Jenburkt expanded into the OTC market with the launch of Jenburkt Wellness, introducing products like Zixa Strong, a natural pain relief solution, and Nervijen D3 tablets in 2022-23. With a commitment to accessible healthcare, Jenburkt continues to innovate under the legacy of its visionary founder, Shri Nandlal Mulji Bhuta.
